Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acetazolamide-induced renal calculi.

M A Rubenstein, J G Bucy

    The Journal of Urology
    |October 1, 1975
    PubMed
    Summary

    Acetazolamide therapy can increase the risk of urinary calculi (stones), especially in patients with a history of stones or surgery. Combining acetazolamide with sodium bicarbonate further elevates this risk.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Visual laser ablation of the prostate: clinical experience in 108 patients.

    The Journal of urology·1993
    Same author

    Submucosal ureteral calculi: a new entity?

    The Journal of urology·1990
    Same author

    Extracorporeal shock wave lithotripsy and the ureteral stone brush: initial results.

    The Journal of urology·1990
    Same author

    Use of stone brush for treatment of impacted stones in association with extracorporeal shock-wave lithotripsy.

    Urology·1990
    Same author

    Variation on Water-Pik technique for treatment of steinstrasse after ESWL.

    Urology·1988
    Same author

    Extracorporeal shock-wave lithotripsy. A urologist's perspective on gallstone crushing.

    Journal of clinical gastroenterology·1987

    Area of Science:

    • Nephrology
    • Urology
    • Pharmacology

    Background:

    • Acetazolamide is a carbonic anhydrase inhibitor used to treat conditions like glaucoma and epilepsy.
    • Urinary calculi formation is a complex process influenced by various factors, including medication use.

    Observation:

    • This study describes the occurrence of urinary calculi in patients undergoing acetazolamide therapy.
    • A specific focus is placed on patient history and concurrent medication use.

    Findings:

    • Patients with a prior history of urinary stones or urinary tract surgery are at a significantly increased risk of developing new calculi during acetazolamide treatment.
    • The concurrent administration of sodium bicarbonate with acetazolamide substantially potentiates the risk of urinary calculus formation.

    Implications:

    • Clinicians should exercise caution when prescribing acetazolamide to patients with a history of urinary stones or surgery.
    • Careful consideration of concurrent medications, particularly sodium bicarbonate, is crucial to mitigate the risk of acetazolamide-induced urinary calculi.
    • Further research may be warranted to explore preventative strategies or alternative treatments for at-risk populations.

    Related Experiment Videos